SOLJULI
Lupin Limited
Mark For: SOLJULI™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88662039 |
| Mark Literal Elements | SOLJULI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | NEW APPLICATION PROCESSING 2019-10-24 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Robert L. Powley |
| Attorney Name | Robert L. Powley |
| Attorney Docket Number | 390.268(US-3 |
Timeline
| 2019-10-21 | Application Filed |
| 2019-10-24 | Location: NEW APPLICATION PROCESSING |
| 2019-10-24 | Status: Live/Pending |
| 2019-10-24 | Status: New application will be assigned to an examining attorney approximately 3 months after filing date. |
| 2019-10-25 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Lupin Limited |
| Address | Bandra Kurla Complex; Bandra (W) B/4 Laxmi Towers Mumbai INDIA 400051 |
| Legal Entity Type | Limited Company (ltd.) |
| Legal Entity State | INDIA |
Documents
 Drawing | JPEG | 2019-10-21 |
 TEAS RF New Application | MULTI | 2019-10-21 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-24 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-10-24 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SOLJULI 98007303 not registered Live/Pending |
Lupin Limited 2023-05-22 |
 SOLJULI 88662039 not registered Live/Pending |
Lupin Limited 2019-10-21 |
 SOLJULI 87100848 not registered Live/Pending |
Lupin Limited 2016-07-12 |
 SOLJULI 85830636 not registered Dead/Abandoned |
Lupin Limited 2013-01-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 